Article
Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration.
Journal of cellular biochemistry - 1 Jul 2007
Hayashi Chikako, Rittling Susan, Hayata Tadayoshi, Amagasa Teruo, Denhardt David, Ezura Yoichi, Nakashima Kazuhisa, Noda Masaki
Abstract excerpt
Tumor malignancy is associated with several features such as proliferation ability and frequency of metastasis. Since tumor metastasis shortens patients' lifetime, establishment of therapy for anti-metastasis is very important. Osteopontin (OPN), which abundantly expressed in bone matrix, is involved in cell adhesion, migration, extracellular matrix (ECM) invasion and cell proliferation via interaction with its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
